Novo Nordisk and OpenAI Partner to Speed Drug Discovery and Manufacturing
Danish pharmaceutical giant Novo Nordisk has signed a strategic partnership with OpenAI to deploy AI across drug discovery, clinical trials, manufacturing, and corporate operations, with full integration planned by the end of 2026.
Novo Nordisk
Read more →